Drug development

The development of biotechnologically produced drugs has made it possible to treat diseases at their cause, to do this more efficiently and with fewer side effects, or even to cure diseases. This is the focus of five biotechnology companies on Campus Berlin-Buch.

The spectrum of their drug development includes highly specific cancer antibodies (Glycotope GmbH), novel treatments targeting the cause of heart failure (Berlin Cures GmbH) or atrial fibrillation (OMEICOS Therapeutics GmbH), extremely effective antibiotics (MerLion Pharmaceuticals) and RNAi-based therapeutics for systemic cancers that can selectively regulate disease-related genes (Silence Therapeutics). Here, T-Knife, a spin-off from the Charité and the Max Delbrück Center, is developing one of the first T cell receptor gene therapies in Germany.

Curofin Pharma GmbH
T-Knife GmbH
Turin Therapeutics UG

News innovation

Eckert & Ziegler Signs Licence Agreement for Actinium-225 with Chinese Joint Venture

Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) today signed a licence agreement with Qi Kang Medical, Ltd (QKM), a joint venture between Eckert & Ziegler and the Chinese company DC Pharma, for the cy...

more ...

Eckert & Ziegler and GlyTherix Extend Collaboration With Actinium-225 Supply Agreement

Eckert & Ziegler (ISIN DE0005659700, SDAX) and GlyTherix Ltd (GlyTherix), an Australian targeted radiotherapy company specialising in developing antibody radiopharmaceuticals for solid tumors, today a...

more ...

Eckert & Ziegler Submits GalliaPharm® for Approval by Japan’s Health Authority MHLW

Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler), a leading provider of isotope technology for nuclear medicine and radiopharmaceutical applications, announces the submission of its GalliaPharm® 6...

more ...

Events Campus

29.01.2025, 16:00
Labor trifft Lehrer*in: "Animal models for mental health disorders"

Online-Kurs für Lehrkräfte mit Hanna Hörnberg (in englischer Sprache)

more ...

30.01.2025, 17:00
Neujahrskonzert

Der Freundeskreis des Max Delbrück Center lädt ein zum Benifizkonzert mit jungen Talenten unter der Leitung von Prof. Galina Iwanzowa-Bielka.

more ...

26.02.2025, 10:00
JUGEND FORSCHT – 60. Regional-Wettbewerb „Macht aus Fragen Antworten”

Die Pateneinrichtungen des Campus Berlin-Buch richten erneut den Regionalwettbewerb aus

more ...

Sponsoren der Website: